 Anaemia

 Hypersensitivity, Abdominal pain

 Diarrhoea, flatulence, vomiting

When pregnancy is diagnosed, treatment with angiotensin II receptor antagonists should be

stopped immediately, and, if appropriate, alternative therapy should be started.

Hepatic impairment: Telmisartan is not to be given to patients with cholestasis, biliary

obstructive disorders or severe hepatic impairment since telmisartan is mostly eliminated with

the bile.

Renovascular hypertension: There is an increased risk of severe hypotension and renal

insufficiency when patients with bilateral renal artery stenosis or stenosis of the artery to a single

functioning kidney are treated with medicinal products that affect the renin-angiotensin-

aldosterone system.

Diabetic patients treated with insulin or antidiabetics: In these patients hypoglycaemia may

occur under telmisartan treatment. Therefore, in these patients an appropriate blood glucose

monitoring should be considered; a dose adjustment of insulin or antidiabetics may be   required,

when indicated.

10 X 10 Tablets.